# A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer

> **NCT00563095** · NA · UNKNOWN · sponsor: **Hospital Authority, Hong Kong** · enrollment: 100 (estimated)

## Conditions studied

- Carcinoma, Hepatocellular

## Interventions

- **PROCEDURE:** Transcatheter Arterial Chemoembolization (TACE)
- **PROCEDURE:** Transcatheter Arterial Pegylated Interferon Embolization (TAIE)

## Key facts

- **NCT ID:** NCT00563095
- **Lead sponsor:** Hospital Authority, Hong Kong
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2008-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2010-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00563095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00563095, "A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00563095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*